Margetuximab: An active alternative for later-line therapy in patients with HER2-positive advanced breast cancer.
作者信息
Zhou Yunxiang, Wang Xiaojia, Chen Yiding
机构信息
Department of Breast Surgery and Oncology The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang China.
Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education) The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou Zhejiang China.
出版信息
MedComm (2020). 2023 Jul 4;4(4):e322. doi: 10.1002/mco2.322. eCollection 2023 Aug.
Abstract
摘要
Zotero 插件